Radioimmunotherapy targeting the HIV gp41 glycoprotein destroyed residual reservoirs of HIV infected cells in the blood samples of patients treated with antiretrovirals. In an interview at the annual meeting of the Radiological Society of North America, Dr. Ekaterina Dadachova discusses the findings and the next steps for testing the approach in patients with HIV.